impact factor
logo
 

Letters to the Editor

 

Persistence of focal lymphocytic sialadenitis in patients with primary Sjögren’s syndrome treated with rituximab: a possible role for glandular BAFF


1, 2, 3, 4, 5, 6, 7

 

  1. Department of Biotechnological and Applied Clinical Sciences, Rheumatology Unit, University of L’Aquila, Italy; and Department of Medicine, ASL 1 Avezzano-Sulmona-L’Aquila, Italy. francescocarubbi@libero.it
  2. Department of Biotechnological and Applied Clinical Sciences, Rheumatology Unit, University of L’Aquila, Italy.
  3. Department of Biotechnological and Applied Clinical Sciences, Rheumatology Unit, University of L’Aquila, Italy.
  4. Department of Biotechnological and Applied Clinical Sciences, Rheumatology Unit, University of L’Aquila, Italy.
  5. Department of Medicine, Rheumatology Unit, University of Perugia, Italy.
  6. Department of Medicine, Rheumatology Unit, University of Perugia, Italy.
  7. Department of Biotechnological and Applied Clinical Sciences, Rheumatology Unit, University of L’Aquila, Italy.

CER9090
2016 Vol.34, N°6
PI 1123, PF 1124
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

PMID: 27494407 [PubMed]

Received: 02/11/2015
Accepted : 17/02/2016
In Press: 02/08/2016
Published: 28/11/2016

Rheumatology Article